ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Federal criminal charges have been filed against National Institutes of Health scientist Pearson (Trey) Sunderland III for inappropriately accepting $285,000 in consulting fees and travel expenses from a drug company. He faces a maximum penalty of one year in jail and a fine of $100,000.
The charges stem from Sunderland's activities from 1998 to 2004 when he served as chief of the Geriatric Psychiatry Branch at NIH's National Institute of Mental Health (NIMH). During that time, his department sent hundreds of government-owned tissue and fluid samples from Alzheimer's patients to Pfizer for study. The conflict-of-interest problems arose when he accepted consulting and other fees from the company during this period without gaining prior permission or disclosing the income properly.
Allegations against Sunderland and other NIH researchers first came to light in 2004 and have been the subject of agency, congressional, and criminal investigations. As a result, NIH imposed a tough set of conflict-of-interest rules that limit the activities of its employees (C&EN, Sept. 5, 2005, page 14), and Congress held a series of hearings, with the most recent calling for the agency and the Department of Justice to take action against Sunderland.
Sunderland is now a special assistant and senior adviser in an external grant division at NIMH. Neither he nor his lawyer is commenting on the charges. NIH also will not comment because the situation deals with a "pending personnel issue."
When C&EN went to press, Sunderland was scheduled to be arraigned on Dec. 8.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter